Skip to content
Find Clinical Trials
Find Clinical Trials

Assessment of the acceptability of a sublingual formulation of piribedil (S90049), 10 to 30 mg on request (maximum 5 times a day) on the top of L-dopa and a dopamine agonist in advanced Parkinson Disease patients with motor fluctuations: a 4-week open label pilot study

Servier Protocol Code: SC3-90049-001 Sponsor: Institut de Recherches Internationales Servier (I.R.I.S) EudraCT Number: 2005-002010-38

Find a recruiting site

Name: Institut de Recherches Internationales Servier, Département des études cliniques
Phone number: +33 1 55 72 60 00

Results
Interventions / Treatments
  • Parkinson's disease
  • PIRIBEDIL
  • S090049
Other study id numbers
  • SC3-90049-001